|
A152T carriers
|
Noncarriers
|
|---|
|
Code
|
Braak
|
Age; Gender
|
Code
|
Braak
|
Age; Gender
|
|---|
|
ADv1
|
5
|
81; F
|
AD1
|
6
|
80; F
|
|
ADv2
|
6
|
96; M
|
AD2
|
5.5
|
91; M
|
|
ADv3
|
6
|
86; M
|
AD3
|
5
|
84; M
|
|
ADv4
|
4.5
|
80; F
|
AD4
|
5
|
80; F
|
|
ADv5
|
6
|
91; F
|
AD5
|
6
|
83; F
|
|
ADv6
|
5
|
67; M
|
AD6
|
6
|
61; M
|
|
PSPv1
|
2
|
67; M
|
PSP1
|
1
|
69; M
|
|
PSPv2
|
3
|
74; F
|
PSP2
|
3
|
74; M
|
|
PSPv3
|
1
|
81; F
|
PSP3
|
1
|
80; F
|
|
PSPv4
|
3
|
77; M
|
PSP4
|
2.5
|
76; M
|
|
PSPv5
|
3
|
77; F
|
PSP5
|
3.5
|
81; F
|
|
LBDv1
|
3
|
75; M
|
LBD1
|
3.5
|
72; M
|
|
LBDv2
|
2.5
|
72; M
|
LBD2
|
0
|
72; M
|
|
CBDv1
|
3
|
68; F
|
CBD1
|
3
|
67; F
|
|
fMNDv1 (C9+)
|
0
|
62; F
|
fMND1 (C9+)
|
2
|
55; F
|
- AD Alzheimer’s disease, PSP Progressive supranuclear palsy, LBD Lewy body dementia, CBD Corticobasal degeneration, fMND (C9+) Frontotemporal lobar degeneration with motor neuron disease associated with C9ORF72 mutation
